Chronic fatigue and return to work in cancer survivors
Completed
- Conditions
- cancertumor10027655
- Registration Number
- NL-OMON35940
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
The study population of the prospective cohort study (n=400) will exist of cancer survivors who apply for a WIA benefit at the head office of UWV in Amsterdam, i.e., they approach a 104 weeks period of sick leave and make a first application for WIA benefit.
Exclusion Criteria
1. Clients treated for cancer, who are too ill to visit the UWV office for the WIA assessment.
2. Clients treated for cancer, who do an appeal on WIA benefit due to another somatic or psychiatric disorder.
3. Clients treated for cancer, with prior WAO/WIA benefit.
4. Clients treated for cancer, who are voluntarily insured non-employees.
5. Clients receiving chemo- or radiotherapy
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure of the study is the level of fatigue, measured by<br /><br>the Functional Assessment of Cancer Therapy-Fatigue (FACT-F) scale. This<br /><br>13-item scale is measured on a 5-point scale (range 0-52) , with 0 being the<br /><br>worst possible score and 52 the best. </p><br>
- Secondary Outcome Measures
Name Time Method